ARID1ASMARCA4:

Samantha Kay Wagner1, Ashley S Moon2, Brooke E Howitt3

  • 1Department of Obstetrics & Gynecology, Stanford University, Stanford, CA, USA.

PubMed
概括

具有ARID1A突变和SMARCA4损失的卵巢透明细胞癌没有恶化. 复发性瘤恢复了SMARCA4的表达,这表明SWI/SNF复合体在卵巢癌中的适应性.